Ajay Bansal

Ajay Bansal

Director Financiero/CFO en UROVANT SCIENCES LTD. .
64 años
Health Technology
Commercial Services
Finance

Perfil

Ajay Bansal currently works at Urovant Sciences Ltd., as Chief Financial Officer & SVP-Business Development from 2019.
Mr. Bansal also formerly worked at Capital One Financial Corp., as Director-Operations Analysis from 2002 to 2003, Nektar Therapeutics, as Chief Financial Officer from 2003 to 2006, Lexicon Pharmaceuticals, Inc., as CFO & Executive VP-Business Development in 2010, Tercica, Inc., as CFO & Executive VP-Business Development from 2007 to 2008, Onconova Therapeutics, Inc., as Chief Financial Officer & Secretary from 2014 to 2016, ViewRay Technologies, Inc., as Chief Financial & Accounting Officer, Complete Genomics, Inc., as Chief Financial Officer from 2012 to 2013, ViewRay, Inc., as Chief Financial & Accounting Officer from 2016 to 2019, McKinsey & Co., Inc., as Engagement Manager from 1988 to 1991, Mehta Partners LLC, as Partner from 1998 to 2002, ZS Associates, Inc., as Consultant from 1985 to 1987, and Novartis Pharmaceuticals Corp., as Principal.
Mr. Bansal received his graduate degree in 1985 and Masters Business Admin degree in 1985 from Northwestern University and undergraduate degree in 1984 from Indian Institute of Technology New Delhi.

Cargos activos de Ajay Bansal

EmpresasCargoInicio
UROVANT SCIENCES LTD. Director Financiero/CFO 28/10/2019

Antiguos cargos conocidos de Ajay Bansal.

EmpresasCargoFin
VIEWRAY SYSTEMS, INC. Director Financiero/CFO 30/09/2019
TRAWS PHARMA, INC. Director Financiero/CFO 12/02/2016
COMPLETE GENOMICS, INC. Director Financiero/CFO 01/03/2013
LEXICON PHARMACEUTICALS, INC. Director Financiero/CFO 08/01/2010
Director Financiero/CFO 01/10/2008
Ver el detalle de la experiencia de Ajay Bansal.

Formación de Ajay Bansal.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

68

Relaciones de 1er grado

15

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas15

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Finance

Commercial Services

Consumer Services

Consumer Services

Health Technology

Health Technology

-40%: Ampliación de plazo extraordinaria
d
:
:
APROVECHAR LA PROMOCIÓN